Navigation Links
Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement
Date:9/27/2010

SYDNEY, Sept. 27 /PRNewswire/ -- Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute of Medical Research (Sydney, Australia) today announced that they have entered into a license agreement in relation to novel biomarkers discovered by scientists at the Garvan Institute. Under the terms of the agreement, Clinical Genomics obtains worldwide exclusive rights to the Garvan's proprietary cancer associated methylation DNA biomarkers for the diagnosis and or treatment of colorectal cancer. Clinical Genomics intends to expand its colorectal biomarker research program to evaluate these promising biomarkers in view of formulating a diagnostic test utilizing those biomarkers demonstrating clinical benefit for the early detection of colorectal cancer.

"Through this strategic licensing agreement with the Garvan Institute, we have complemented our existing technology portfolio and enhanced our ability to develop next generation products for diagnosing colorectal cancer at the earliest, most treatable stage," stated Dr. Lawrence LaPointe, Chief Executive Officer of Clinical Genomics. "We have also broadened our product development options for ourselves and our partners."

"This licensing agreement will allow Clinical Genomics to achieve the full diagnostic potential of the colorectal cancer biomarkers identified by our researchers," said Professor John Shine, Executive Director of Garvan. "Our hope is that the company will successfully develop a diagnostic tool that will be useful in the global effort to treat this common cancer."

About DNA Methylation

DNA methylation is a naturally occurring biological process involved in gene silencing. In 2005, a team led by Prof. Susan Clarke at the Garvan Institute of Medical Research published a paper in Nature Genetics describing a region of the human genome that shows much higher levels of methylation (silencing) in colorectal cancer compared to healthy controls.

About The Garvan
'/>"/>

SOURCE Clinical Genomics Pty Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMDs TCT Satellite Symposium in Washington DC., Today.
2. Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis
3. China Pharma Holdings, Inc. Successfully Completes Phase I Clinical Trials of New Anti-Drug-Resistance Antibiotic
4. OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
5. Santaris Pharma A/S Advances miravirsen, the First microRNA-Targeted Drug to Enter Clinical Trials, Into Phase 2 to Treat Patients Infected With Hepatitis C Virus
6. 2010 Lasker Awards Honor Trailblazers in Medical Research and Clinical Care
7. Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC
8. Stemedica Announces Completion of Clinical Stem Cell Master Bank
9. Paratek to Present Clinical Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
10. ChromaDex Commences a Clinical Trial on pTeroPureā„¢ Pterostilbene
11. InSightec Treats First Prostate Cancer Patients in Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... worldwide rely on sophisticated equipment, trained personnel, and ... areas against terrorist attacks. A revolutionary new electronic ... make their job much easier. , The groundbreaking ... Tel Aviv University ,s School of Chemistry and ... the Herzliya company Tracense, picks up the scent ...
(Date:7/24/2014)... processes prefer to settle into equilibriuma state of ... the realm of non-equilibrium conditions where new possibilities ... and phases, such as temperature fluctuations, freezing and ... regulate their body temperature, airplanes to fly, and ... , But even though these conditions exist naturally ...
(Date:7/24/2014)... , July 24, 2014 SRI International ... with the National Institute of Allergy and Infectious Diseases ... conduct preclinical development of potential therapies for HIV infection ... to treat HIV and AIDS and the complications and ... microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... LANSING, Mich. , July 24, 2014  Neogen ... today that future forecasts of its potential revenue from ... conference call to investors and analysts on July 22, ... questioned by analysts regarding this research. "It ... answer questions about the potential of a new type ...
Breaking Biology Technology:Nano-sized chip 'sniffs out' explosives far better than trained dogs 2New approach to form non-equilibrium structures 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3Neogen comments on SenesTech 2
... SectorWatch.biz announces the,availability of MarketStats on public equities ... Investors can view all of SectorWatch.biz MarketStats ... Click on MarketStats, Today,s MarketStats on Healthcare ... Bulletin Board: CVBT), Boston,Scientific Corp. (NYSE: BSX ...
... DIEGO, Feb. 14 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ... and,year-end 2007 financial results on Wednesday, February 20, 2008, ... a conference call and webcast to discuss its fourth,quarter ... its,development programs on Wednesday, February 20, 2008 at 5:00 ...
... Feb. 14 AspenBio Pharma,Inc. (Nasdaq: APPY ) ... drugs and diagnostics for animals and humans, has been,invited ... Growth Stock,Conference. The conference will be held February 18-21, ... California., Roth Capital Partners Stock Conferences are one ...
Cached Biology Technology:SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA 2Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results 2AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference 2
(Date:7/27/2014)... at Barts Cancer Institute have found that targeting a ... more effective, according to research published in Nature ... part of Queen Mary University of London, have found ... the body to repair itself after chemotherapy or radiotherapy, ... researchers removed FAK from blood vessels that grew in ...
(Date:7/25/2014)... 100,000s of people lived on the land now called ... control the availability of plants they used for food, ... fire to maintain desired habitat and natural resources. , ... Pacific Southwest Station, will lead a field trip ... the Ecological Society of America,s 99th Annual Meeting, in ...
(Date:7/25/2014)... study published online in the International Journal of ... to preventing cervical cancer based on findings showing successful ... of a discrete population of cells in the cervix. ... looked at squamocolumnar junction cells, or SCJ cells. These ... implicated as the origins of cervical cancer. A research ...
Breaking Biology News(10 mins):New drug target can break down cancer's barrier against treatment 2Fire ecology manipulation by California native cultures 2Fire ecology manipulation by California native cultures 3Clearing cells to prevent cervical cancer 2
... The New York Genome Center (NYGC) announced today ... become an Associate Member, joining NYGC,s growing consortium of ... new ways to utilize genomic data for better detection, ... NYSCF working with the genomic scientists at NYGC will ...
... an excellent economics teacher, but some would be surprised to ... is cleaner than the first breath they ever took. ... that improvements in U.S. air quality since 1990 have sparked ... to air pollution. Pope was a member of a large ...
... of popular soft drinks, alters the brain,s perception of ... determine the difference between sugar and artificial sweeteners, according ... official journal of the American Gastroenterological Association. ... and artificial sweeteners can leave the sweet taste of ...
Cached Biology News:New York Genome Center announces the New York Stem Cell Foundation as an Associate Member 2New York Genome Center announces the New York Stem Cell Foundation as an Associate Member 3Death & disability from air pollution down 35 percent in the US 2Carbonation alters the mind's perception of sweetness 2
... FX provides complete solutions for ... With 96-, 384-, and independent ... either single or dual arm ... maximum speed and flexibility for ...
... fixed-angle microcentrifuge rotor at RCF up ... filters consist of a membrane-containing filter ... filter by centrifugation for bacteria removal, ... of cells from media and DNA ...
... System provides high-throughput, quantitative gene expression analysis ... patented priming strategy overcomes the biases that ... a few genes at a time. ... and more samples per run, removing bottlenecks ...
... Detergent-OUT Kit is a simple high performance ... Removes detergents without significant dilution of ... solution on the Detergent-OUT Spin column and ... Med column is suitable for removing detergents ...
Biology Products: